157 related articles for article (PubMed ID: 3802092)
1. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092
[TBL] [Abstract][Full Text] [Related]
2. Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody.
Endo N; Takeda Y; Kishida K; Kato Y; Saito M; Umemoto N; Hara T
Cancer Immunol Immunother; 1987; 25(1):1-6. PubMed ID: 3496155
[TBL] [Abstract][Full Text] [Related]
3. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody.
Umemoto N; Kato Y; Hara T
Cancer Immunol Immunother; 1989; 28(1):9-16. PubMed ID: 2783302
[TBL] [Abstract][Full Text] [Related]
6. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.
Umemoto N; Kato Y; Takeda Y; Saito M; Hara T; Seto M; Takahashi T
J Appl Biochem; 1984; 6(5-6):297-307. PubMed ID: 6443109
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
Yin Z
Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
[TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760
[TBL] [Abstract][Full Text] [Related]
10. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
Shen WC; Ballou B; Ryser HJ; Hakala TR
Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
Seto M; Takahashi T; Nakamura S; Matsudaira Y; Nishizuka Y
Cancer Res; 1983 Oct; 43(10):4768-73. PubMed ID: 6192909
[TBL] [Abstract][Full Text] [Related]
12. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary.
Pietersz GA; Cunningham Z; McKenzie IF
Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
14. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
[TBL] [Abstract][Full Text] [Related]
15. Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biologic activity.
Manabe Y; Tsubota T; Haruta Y; Kataoka K; Okazaki M; Haisa S; Nakamura K; Kimura I
J Lab Clin Med; 1984 Sep; 104(3):445-54. PubMed ID: 6206174
[TBL] [Abstract][Full Text] [Related]
16. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
[TBL] [Abstract][Full Text] [Related]
17. Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugate.
Haenseler E; Esswein A; Vitols KS; Montejano Y; Mueller BM; Reisfeld RA; Huennekens FM
Biochemistry; 1992 Jan; 31(3):891-7. PubMed ID: 1731945
[TBL] [Abstract][Full Text] [Related]
18. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
19. Drug/antibody conjugates. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
Acta Paediatr Jpn; 1987 Aug; 29(4):566-8. PubMed ID: 3144892
[No Abstract] [Full Text] [Related]
20. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
Taheri A; Dinarvand R; Atyabi F; Ghahremani MH; Ostad SN
Eur J Pharm Sci; 2012 Sep; 47(2):331-40. PubMed ID: 22771547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
